1 unknown. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Unknown 1 |
Follow Anxiety Disorder Generalized: new trials by email Literature Review of Anxiety Disorder Generalized trials Research Report on Anxiety Disorder Generalized
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Assess the Efficacy and Safety of CD-008-0045 in Patients With Generalized Anxiety Disorder CD-008-0045, Placebo, Afobazol - Anxiety Disorder Generalized | Phase 3 | Unknown | ChemRar Research and Development Institute, LLC | 200 | 2020-12-01 | 2020-10-22 |
Generalized Anxiety Disorder (1)
Anxiety Disorders (1) · Mental Disorders (1)
2-((2-morpholino)ethylthio)-5-ethoxybenzimidazole (1)
ChemRar Research and Development Institute, LLC (1)